This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignees: Life Science Institute, Inc., Tohoku University. Active years: 2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 3 
1 out of 1,051 
Years Active: 2022
Title: Katsuhiro Hosoyama: Innovator in Vascular Treatment
Introduction
Katsuhiro Hosoyama is a notable inventor based in Sendai, Japan. He has made significant contributions to the field of medical science, particularly in the treatment of vascular disorders. His innovative approach has led to the development of a unique method that addresses critical health issues.
Latest Patents
Katsuhiro Hosoyama holds a patent for a method of treating aortic aneurysm using muse cells. This patent describes a cell product designed for the prevention and/or treatment of vascular disorders, such as aortic aneurysm. The product comprises SSEA-3-positive pluripotent stem cells derived from mesenchymal tissue in a living body or cultured mesenchymal cells, known as Muse cells. He has 1 patent to his name.
Career Highlights
Throughout his career, Katsuhiro has worked with prominent organizations, including Life Science Institute, Inc. and Tohoku University. His work in these institutions has allowed him to advance his research and contribute to the scientific community.
Collaborations
Katsuhiro has collaborated with esteemed colleagues, including Yoshikatsu Saiki and Mari Dezawa. These partnerships have enriched his research and fostered innovation in the field of vascular treatment.
Conclusion
Katsuhiro Hosoyama is a pioneering inventor whose work in treating aortic aneurysms has the potential to transform medical practices. His dedication to research and collaboration continues to inspire advancements in healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile